Viewing Study NCT03964168


Ignite Creation Date: 2025-12-24 @ 6:30 PM
Ignite Modification Date: 2025-12-30 @ 2:30 AM
Study NCT ID: NCT03964168
Status: COMPLETED
Last Update Posted: 2020-03-11
First Post: 2019-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
Sponsor: Psoriasis Treatment Center of Central New Jersey
Organization:

Study Overview

Official Title: An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
Status: COMPLETED
Status Verified Date: 2020-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.
Detailed Description: Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: